FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pawel Grieb

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Phenomena

Magnetic Resonance Spectroscopy

Co-author Network

Publications

TOP 3
Konrad Rejdak; Robert Rejdak; Stephan Rüegg; Zbigniew Stelmasiak; Dorota Sulejczak; Jens Kuhle; Raija L P Lindberg; Ewa Papuc; Axel Petzold; Pawel Grieb
Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury.
Sebastian Thaler; Michal Wozniak; Zbigniew Wypych; Katarzyna Zawada; Eberhart Zrenner; Tomasz Borowik; Michal Fiedorowicz; Pawel Grieb; Jaroslaw Kaminski; Narcyz Knap; Robert Rejdak; Frank Schuettauf
Neuroprotective effects of tempol acyl esters against retinal ganglion cell death in a rat partial optic nerve crush model.
Michal Fiedorowicz; Wojciech Dyda; Robert Rejdak; Pawel Grieb
Magnetic resonance in studies of glaucoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pawel Grieb (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Konrad Rejdak; Robert Rejdak; Stephan Rüegg; Zbigniew Stelmasiak; Dorota Sulejczak; Jens Kuhle; Raija L P Lindberg; Ewa Papuc; Axel Petzold; Pawel Grieb
Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury.
Epilepsia 2012;53(5):922-7.
2011: Sebastian Thaler; Michal Wozniak; Zbigniew Wypych; Katarzyna Zawada; Eberhart Zrenner; Tomasz Borowik; Michal Fiedorowicz; Pawel Grieb; Jaroslaw Kaminski; Narcyz Knap; Robert Rejdak; Frank Schuettauf
Neuroprotective effects of tempol acyl esters against retinal ganglion cell death in a rat partial optic nerve crush model.
Acta ophthalmologica 2011;89(7):e555-60.
2011: Michal Fiedorowicz; Wojciech Dyda; Robert Rejdak; Pawel Grieb
Magnetic resonance in studies of glaucoma.
Medical science monitor : international medical journal of experimental and clinical research 2011;17(10):RA227-32.
2011: Robert Rejdak; Frank Schuettauf; Sebastian Thaler; Waldemar A Turski; Tomasz Zarnowski; Tomasz Chorągiewicz; Pawel Grieb; Anselm Junemann; Eberhart Zrenner
Kynurenic acid and kynurenine aminotransferases in retinal aging and neurodegeneration.
Pharmacological reports : PR 2011;63(6):1324-34.
2011: Robert Rejdak; Carmen Rummelt; Sebastian Thaler; Waldemar Turski; Eberhart Zrenner; Friedrich Kruse; Katarzyna Nowomiejska; Etsuo Okuno; Konrad Rejdak; Pawel Grieb; Anselm Gm Junemann
Presence of L-kynurenine aminotransferase III in retinal ganglion cells and corpora amylacea in the human retina and optic nerve.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2011;49(2):132-7.
2010: Pawel Stasiak; Malgorzata Sznitowska; Carsten Ehrhardt; Maria Luczyk-Juzwa; Pawel Grieb
In vivo assessment of parenteral formulations of oligo(3-hydroxybutyric Acid) conjugates with the model compound Ibuprofen.
AAPS PharmSciTech 2010;11(4):1636-41.
2010: Janina Rafalowska; Malgorzata Modrzewska-Lewczuk; Hanna Chrzanowska; Dorota Dziewulska; Roman Gadamski; Pawel Grieb
Is the spinal cord motoneuron exclusively a target in ALS? Comparison between astroglial reactivity in a rat model of familial ALS and in human sporadic ALS cases.
Neurological research 2010;32(8):867-72.
2010: Hanna Lawnicka; Magdalena Kowalewicz-Kulbat; Paulina Sicinska; Zygmunt Kazimierczuk; Pawel Grieb; Henryk Stepien
Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro.
Cell and tissue research 2010;340(2):371-9.
2010: Sebastian Thaler; Michal Fiedorowicz; Robert Rejdak; Tomasz J Choragiewicz; Dorota Sulejczak; Piotr Stopa; Tomasz Zarnowski; Eberhart Zrenner; Pawel Grieb; Frank Schuettauf
Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load.
Experimental eye research 2010;90(2):254-60.
2010: Ewa Nagańska; Anna Taraszewska; Ewa Matyja; Pawel Grieb; Janina Rafałowska
Neuroprotective effect of erythropoietin in amyotrophic lateral sclerosis (ALS) model in vitro. Ultrastructural study.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2010;48(1):35-44.
2010: Malgorzata Halon; Alicja Sielicka-Dudzin; Michal Wozniak; Wieslaw Ziolkowski; Walenty Nyka; Magdalena Herbik; Pawel Grieb; Adam Figarski; Jedrzej Antosiewicz
Up-regulation of ferritin ubiquitination in skeletal muscle of transgenic rats bearing the G93A hmSOD1 gene mutation.
Neuromuscular disorders : NMD 2010;20(1):29-33.
2009: Zbigniew Stelmasiak; J Solski; J Nowicki; B Jakubowska; M Ryba; Pawel Grieb
Effect of parenteral cladribine on relapse rates in patients with relapsing forms of multiple sclerosis: results of a 2-year, double-blind, placebo-controlled, crossover study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(6):767-70.
2009: Konrad Rejdak; Ewa Papuć; Pawel Grieb; Zbigniew Stelmasiak
Decreased cerebrospinal fluid hypocretin-1 (orexin A) in patients after repetitive generalized tonic-clonic seizures.
Epilepsia 2009;50(6):1641-4.
2008: Dorota Sulejczak; Pawel Grieb; Michal Walski; Malgorzata Frontczak-Baniewicz
Apoptotic death of cortical neurons following surgical brain injury.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2008;46(3):213-9.
2008: Michał Fiedorowicz; Dorota Makarewicz; Kinga I Stańczak-Mrozek; Pawel Grieb
CDP-choline (citicoline) attenuates brain damage in a rat model of birth asphyxia.
Acta neurobiologiae experimentalis 2008;68(3):389-97.
2008: Ewa Matyja; Anna Taraszewska; Ewa Nagańska; Pawel Grieb; Janina Rafałowska
CDP-choline protects motor neurons against apoptotic changes in a model of chronic glutamate excitotoxicity in vitro.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2008;46(2):139-48.
2007: Katarzyna Sklinda; Paweł Bargiel; Artur Przelaskowski; Tomasz Bulski; Jerzy Walecki; Pawel Grieb
Multiscale extraction of hypodensity in hyperacute stroke.
Medical science monitor : international medical journal of experimental and clinical research 2007;13 Suppl 1():5-10.
2007: Tomasz Kryczka; Zygmunt Kazimierczuk; Mariola Kozłowska; Stanislaw J Chrapusta; Leena Vilpo; Juhani Vilpo; Krzysztof Stachnik; Monika Janisz; Pawel Grieb
Two novel nucleoside ester derivatives of chlorambucil as potential antileukemic prodrugs: a preliminary study.
Anti-cancer drugs 2007;18(3):301-10.
2007: Irena Niebroj-Dobosz; Janina Rafałowska; Anna Fidziańska; Roman Gadamski; Pawel Grieb
Myelin composition of spinal cord in a model of amyotrophic lateral sclerosis (ALS) in SOD1G93A transgenic rats.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2007;45(4):236-41.
2007: Robert Rejdak; Carmen Rummelt; Eberhart Zrenner; Pawel Grieb; Tomasz Zarnowski; Etsuo Okuno; Ursula Schlötzer-Schrehardt; Gottfried Naumann; Friedrich E Kruse; Anselm Jünemann
Immunohistochemical identification of kynurenine aminotransferases in corpora amylacea in the human retina and optic nerve.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2007;45(2):66-71.
2007: Konrad Rejdak; Axel Petzold; Tomasz Kocki; Jacek Kurzepa; Pawel Grieb; Waldemar A Turski; Zbigniew Stelmasiak
Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(8):1011-5.
2007: Tomasz Zarnowski; Robert Rejdak; Elzbieta Zielinska-Rzecka; Eberhart Zrenner; Pawel Grieb; Zbigniew Zagórski; Anselm Junemann; Waldemar A Turski
Elevated concentrations of kynurenic acid, a tryptophan derivative, in dense nuclear cataracts.
Current eye research 2007;32(1):27-32.
2006: Frank Schuettauf; Robert Rejdak; Sebastian Thaler; Sylvia Bolz; Cristiana Lehaci; Anna Mankowska; Tomasz Zarnowski; Anselm Junemann; Zbigniew Zagorski; Eberhart Zrenner; Pawel Grieb
Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat.
Experimental eye research 2006;83(5):1128-34.
2006: Andrzej Rubaj; Piotr Ruciński; Konrad Rejdak; Krzysztof Oleszczak; Dariusz Duma; Pawel Grieb; Andrzej Kutarski
Biventricular versus right ventricular pacing decreases immune activation and augments nitric oxide production in patients with chronic heart failure.
European journal of heart failure 2006;8(6):615-20.
2006: Anna Fidziańska; Janina Rafałowska; Hanna Chrzanowska; Roman Gadomski; Pawel Grieb
Ultrastructural changes in lumbar spinal cord in transgenic SOD1G93A rats.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2006;44(3):175-82.
2006: Janina Rafałowska; Anna Fidziańska; Dorota Dziewulska; Wanda Ogonowska; Roman Gadomski; Pawel Grieb
Progression of morphological changes within CNS in a transgenic rat model of familial amyotrophic lateral sclerosis.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2006;44(3):162-74.
2006: Roman Gadomski; Stanislaw J Chrapusta; Renata Wojda; Pawel Grieb
Morphological changes and selective loss of motoneurons in the lumbar part of the spinal cord in a rat model of familial amyotrophic lateral sclerosis (fALS).
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2006;44(3):154-61.
2006: Magdalena A Herbik; Stanislaw J Chrapusta; Anna Kowalczyk; Pawel Grieb
Maintenance of the rat transgenic model of familial amyotrophic lateral sclerosis expressing human SOD1G93A mutation.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2006;44(3):149-53.
2005: Tomasz Kryczka; Krzysztof Stachnik; Mariola Kozłowska; Zygmunt Kazimierczuk; Jari Hovinen; Stanislaw J Chrapusta; Pawel Grieb
Synthesis and preliminary in vitro evaluation of 5'-O-esters of 2'-deoxyadenosine and 2-chloro-2'-deoxyadenosine with alpha-lipoic acid as potential prodrugs.
Acta poloniae pharmaceutica 2005;62(5):411-5.
2005: Janusz S Skierski; Miroslawa Koronkiewicz; Pawel Grieb
Tezacitabine blocks tumor cells in G1 and S phases of the cell cycle and induces apoptotic cell death.
Acta poloniae pharmaceutica 2005;62(3):195-205.
2005: Krzysztof Stachnik; Pawel Grieb; Janusz S Skierski
Cytotoxic effects of cladribine and tezacitabine toward HL-60.
Acta biochimica Polonica 2005;52(2):561-5.
2004: Pawel Grieb
[5-Aminolevulinic acid (ALA) and its applications in neurosurgery].
Neurologia i neurochirurgia polska 2004;38(3):201-7.
2004: Pawel Grieb
[Impaired glucose tolerance and the risk of cardiovascular death].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2004;16(94):394-7.
2004: Frank Schuettauf; Robert Rejdak; Michal Walski; Malgorzata Frontczak-Baniewicz; Michael Voelker; Georgios Blatsios; Kei Shinoda; Zbigniew Zagorski; Eberhart Zrenner; Pawel Grieb
Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension.
Acta neuropathologica 2004;107(4):352-8.
2004: Pawel Grieb
Transgenic models of amyotrophic lateral sclerosis.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2004;42(4):239-48.
2004: Pawel Grieb; Wanda Gordon-Krajcer; Malgorzata Frontczak-Baniewicz; Michal Walski; Miroslaw Ryba; Tomasz Kryczka; Michal Fiedorowicz; Piotr Kulinowski; Zenon Sułek; Katarzyna Majcher; Andrzej Jasiński
2-deoxyglucose induces beta-APP overexpression, tau hyperphosphorylation and expansion of the trans-part of the Golgi complex in rat cerebral cortex.
Acta neurobiologiae experimentalis 2004;64(4):491-502.
2004: Pawel Grieb; Tomasz Kryczka; Michał Fiedorowicz; Malgorzata Frontczak-Baniewicz; Michal Walski
Expansion of the Golgi apparatus in rat cerebral cortex following intracerebroventricular injections of streptozotocin.
Acta neurobiologiae experimentalis 2004;64(4):481-9.
2003: Tomasz Kryczka; Barbara Marciniec; Maria Popielarz-Brzezinska; Maciej Bero; Janusz Kasperczyk; Piotr Dobrzyński; Zygmunt Kazimierczuk; Pawel Grieb
Effect of gamma-irradiation on cladribine and cladribine-containing biodegradable copolymers.
Journal of controlled release : official journal of the Controlled Release Society 2003;89(3):447-56.
2003: Tomasz Kryczka; Pawel Grieb
[Nucleoside analogs in the treatment of primary malignant brain tumors].
Neurologia i neurochirurgia polska 2003;37(3):687-701.
2003: Robert Rejdak; Jerzy Toczołowski; Jacek Kurkowski; Marek L Kamiński; Konrad Rejdak; Zbigniew Stelmasiak; Pawel Grieb
Oral citicoline treatment improves visual pathway function in glaucoma.
Medical science monitor : international medical journal of experimental and clinical research 2003;9(3):PI24-8.
2003: Jerzy Walecki; Eugeniusz Tarasów; Bozena Kubas; Zbigniew Czemicki; Janusz Lewko; Jan Podgórski; Maria Sokól; Pawel Grieb
Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: assessment of the value of the method.
Academic radiology 2003;10(2):145-53.
2003: Dariusz Horsztyński; Iwona Wawer; Pawel Grieb
[A study of lyophylized human brain tumor tissue using MAS 1H-MRS spectroscopy].
Neurologia i neurochirurgia polska 2003;37(1):123-32.
2003: Pawel Grieb; Miroslaw Ryba; Monika Janisz; Michal Walski
Preclinical development of biodegradable polymer foils for intracerebral delivery of cytotoxic nucleosides.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2003;41(2):69-78.
2002: Konrad Rejdak; Halina Bartosik-Psujek; Beata Dobosz; Tomasz Kocki; Pawel Grieb; Gavin Giovannoni; Waldemar A Turski; Zbigniew Stelmasiak
Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients.
Neuroscience letters 2002;331(1):63-5.
2002: Robert Rejdak; Jerzy Toczołowski; Janusz Solski; Dariusz Duma; Pawel Grieb
Citicoline treatment increases retinal dopamine content in rabbits.
Ophthalmic research 2002;34(3):146-9.
2002: Pawel Grieb; Robert Rejdak
Pharmacodynamics of citicoline relevant to the treatment of glaucoma.
Journal of neuroscience research 2002;67(2):143-8.
2002: Tomasz Kryczka; Maciej Bero; Janusz Kasperczyk; Piotr Dobrzyński; Barbara Marciniec; Maria Popielarz-Brzezińska; Pawel Grieb
In vitro release of cytotoxic nucleoside analogs from lactide-caprolactone and lactide-glycolide copolymers.
Acta biochimica Polonica 2002;49(1):205-10.
2002: Pawel Grieb; Tomasz Kryczka; Radosław Wójtowicz; Jerzy Kawiak; Zygmunt Kazimierczuk
5'-Esters of 2'-deoxyadenosine and 2-chloro-2'-deoxyadenosine with cell differentiation-provoking agents.
Acta biochimica Polonica 2002;49(1):129-37.
2001: Pawel Grieb; J Kamienowski; Monika Janisz; P Kuśnierczyk; Jerzy Kawiak; Grazyna Hoser; Stanislaw J Chrapusta
Hematological effects of intermittent 2-hour infusions of cladribine in multiple sclerosis patients: a comparison of 2 dosage patterns.
International journal of hematology 2001;74(4):421-7.
2001: Konrad Rejdak; Robert Rejdak; Maria Sieklucka-Dziuba; Zbigniew Stelmasiak; Pawel Grieb
The effects of citicoline and/or MK-801 on survival, neurological and behavioral outcome of mice exposed to transient hyperglycemia and oligemic hypoxia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11(5):333-41.
2001: Konrad Rejdak; Robert Rejdak; Maria Sieklucka-Dziuba; Zbigniew Stelmasiak; Pawel Grieb
2-deoxyglucose enhances epileptic tolerance evoked by transient incomplete brain ischemia in mice.
Epilepsy research 2001;43(3):271-8.
2001: Robert Rejdak; Konrad Rejdak; Maria Sieklucka-Dziuba; Zbigniew Stelmasiak; Pawel Grieb
Brain tolerance and preconditioning.
Polish journal of pharmacology 2001;53(1):73-9.
2001: Pawel Grieb; Roman Gadamski; Renata Wojda; Monika Janisz
CDP-choline, but not cytidine, protects hippocampal CA1 neurones in the gerbil following transient forebrain ischaemia.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2001;39(3):141-5.
2001: Pawel Grieb; P Pieniazek; M Sokół; Jerzy Walecki
Metabolite ratios measured with a short echo time 1H-MRS in the frontal lobe of young healthy subjects: an approach to generate reference 1H-MRS data.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2001;39(2):57-62.
2000: Stanislaw J Chrapusta; Andrzej Górski; T Mrowiec; Pawel Grieb; Jaroslaw Andrychowski; Miroslaw Ryba
Immune abnormalities in aneurysmal subarachnoid haemorrhage patients: relation to delayed cerebral vasospasm.
Scandinavian journal of immunology 2000;51(4):400-7.
2000: Pawel Grieb; Z Stelmasiak; Konrad Rejdak; Robert Rejdak
[The mechanisms of neuronal death and advances in the neural protection in epilepsy].
Neurologia i neurochirurgia polska 2000;34 Suppl 8():85-93.
2000: Zbigniew Czernicki; D Horsztyński; W Jankowski; Pawel Grieb; J Walecki
Malignancy of brain tumors evaluated by proton magnetic resonance spectroscopy (1H-MRS) in vitro.
Acta neurochirurgica. Supplement 2000;76():17-20.
2000: Tomasz Kryczka; Pawel Grieb; Maciej Bero; Janusz Kasperczyk; Piotr Dobrzynski
Kinetics of a nucleoside release from lactide-caprolactone and lactide-glycolide polymers in vitro.
Acta biochimica Polonica 2000;47(1):59-64.
1999: Janusz S Skierski; Miroslawa Koronkiewicz; Pawel Grieb
Effect of FMdC on the cell cycle of some leukemia cell lines.
Cytometry 1999;37(4):302-7.
1999: Pawel Grieb; Miroslaw Ryba; Janusz Jagielski; W Gackowski; PM Paczkowski; Stanislaw J Chrapusta
Serum cholesterol in cerebral malignancies.
Journal of neuro-oncology 1999;41(2):175-80.
1998: B Buntner; M Nowak; Janusz Kasperczyk; Miroslaw Ryba; Pawel Grieb; Michal Walski; P Dobrzyñski; Maciej Bero
The application of microspheres from the copolymers of lactide and epsilon-caprolactone to the controlled release of steroids.
Journal of controlled release : official journal of the Controlled Release Society 1998;56(1-3):159-67.
1998: Pawel Grieb; Miroslaw Ryba; G S Debicki; Wanda Gordon-Krajcer; S Januszewski; Stanislaw J Chrapusta
Changes in oxidative stress in the rat brain during post-cardiac arrest reperfusion, and the effect of treatment with the free radical scavenger idebenone.
Resuscitation 1998;39(1-2):107-13.
1997: Pawel Grieb; Miroslaw Ryba; J Sawicki; Stanislaw J Chrapusta
Oral coenzyme Q10 administration prevents the development of ischemic brain lesions in a rabbit model of symptomatic vasospasm.
Acta neuropathologica 1997;94(4):363-8.
1996: Tadeusz Robak; M Błasinka-Morawiec; Euzebiusz Krykowski; M Kasznicki; A Płuzanska; Piotr Potemski; Andrzej Hellmann; Jan M Zaucha; Krzysztof Lewandowski; Anna Dmoszynska; Janusz Hansz; Mieczyslaw Komarnicki; Lech Konopka; T Durzynski; B Ceglarek; A Sikorska; Sabina Kotlarek-Haus; G Mazur; Ignacy Urasinski; Barbara Zdziarska; S Maj; I Kopec; Aleksander B Skotnicki; Jadwiga Dwilewicz - Trojaczek; Pawel Grieb
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.
Leukemia & lymphoma 1996;22(5-6):509-14.
1996: Tadeusz Robak; M Błasińska-Morawiec; Euzebiusz Krykowski; Janusz Hansz; Mieczyslaw Komarnicki; M Kazimierczak; Lech Konopka; S Maj; Andrzej Hellmann; Jan M Zaucha; L Urasiński; Barbara Zdziarska; Sabina Kotlarek-Haus; Lidia Usnarska-Zubkiewicz; Z Kuratowska; Jadwiga Dwilewicz - Trojaczek; J Hołowiecki; M Krawczyk-Kulis; Pawel Grieb
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia.
Leukemia & lymphoma 1996;22(1-2):107-11.
1996: Ewa Matyja; Pawel Grieb; Miroslaw Ryba; Janusz Jagielski; Miroslaw J Mossakowski
2-chloro- and 2-bromo-2'-deoxyadenosine have no effect on the morphology of rat neural and glial cells in organotypic culture.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 1996;34(1):41-7.
1996: Ewa Matyja; Pawel Grieb; Miroslaw Ryba; Janusz Jagielski; Miroslaw J Mossakowski
Mitochondrial damage following exposure of organotypic cultures of human malignant gliomas to 2-chloro- and 2-bromo-2'-deoxyadenosine.
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 1996;34(1):31-9.
1995: Pawel Grieb; Zbigniew Stelmasiak; J Solski; J Nowicki; B Jakubowska; Miroslaw Ryba
Effect of repeated treatments with cladribine (2-chlorodeoxyadenosine) on blood counts in multiple sclerosis patients.
Archivum immunologiae et therapiae experimentalis 1995;43(5-6):323-7.
1995: Miroslaw Ryba; Pawel Grieb; W A Janczewski; J Sawicki; Janusz Jagielski; J Andrychowski; J Mantuzyk; M Janisz
Survival and maturation of heterotopic fetal brain stem xenografts after treatment with 2-chlorodeoxyadenosine and cyclosporine A.
Acta neurobiologiae experimentalis 1995;55(4):259-70.
1995: Pawel Grieb; J Skierski; Janusz Jagielski; Miroslaw Ryba; Miroslaw J Mossakowski
DNA protein flow cytometry of dissociated cultures of human anaplastic gliomas. Pattern of proliferation and differentiation, and the effect of a new cytostatic drug cladribine (2-CdA).
Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 1995;33(3):145-52.
1995: Pawel Grieb; Zbigniew Stelmasiak
[Treatment of multiple sclerosis with cladribine (2-CDA), a new immunosuppressant agent. Theoretical basis and preliminary results].
Neurologia i neurochirurgia polska 1995;29(1):69-76.
1994: Pawel Grieb; Miroslaw Ryba; Zbigniew Stelmasiak; J Nowicki; J Solski; B Jakubowska
Cladribine treatment of multiple sclerosis.
Lancet 1994;344(8921):538.
1994: Andrzej Górski; Vincent Castronovo; B Stepień-Sopniewska; Pawel Grieb; M Ryba; T Mrowiec; Grazyna Korczak-Kowalska; Piotr Wierzbicki; W Matysiak; B Dybowska
Depressed immune surveillance against cancer: role of deficient T cell: extracellular matrix interactions.
Cell adhesion and communication 1994;2(3):225-33.
1994: M Gajewska; T Pawiński; A Dzierzgowska-Szmidt; Pawel Grieb; Miroslaw Ryba
Determination of 2-bromo and 2-chloro derivatives of 2'-deoxyadenosine in human blood serum by high performance liquid chromatography.
Acta poloniae pharmaceutica 1994;51(2):109-14.
1994: Miroslaw Ryba; Pawel Grieb; S Majewski; B Makieła; M Pastuszko; J Andrychowski; P Bojarski
Modulation of lymphocyte-fibroblast interactions by 2-chloro-2'-deoxyadenosine (2-CdA) in subarachnoid hemorrhage.
Archivum immunologiae et therapiae experimentalis 1994;42(1):47-9.
1994: Pawel Grieb; Miroslaw Ryba; W Janczewski; J Sawicki; Janusz Jagielski; J Andrychowski
2-Chloro-2'-deoxyadenosine (2-CdA) combined with cyclosporine A successfully prevents rejection of fetal brain stem allograft in rabbits.
Archivum immunologiae et therapiae experimentalis 1994;42(1):43-6.
1994: Jan M Zaucha; D Ciesielski; Pawel Grieb; Andrzej Hellmann
2-Chloro-2'-deoxyadenosine (2-CdA) treatment in a patient with Waldenström's macroglobulinaemia complicated by severe neutrocytopenia.
Archivum immunologiae et therapiae experimentalis 1994;42(1):35-7.
1994: Slawomir Majewski; M Skopińska; M Błaszczyk; Miroslaw Ryba; Pawel Grieb; T Chorzelski; S Jabłońska
Systemic administration of 2-chloro-2'-deoxyadenosine (2-CdA) in patients with systemic scleroderma.
Archivum immunologiae et therapiae experimentalis 1994;42(1):33-4.
1994: Pawel Grieb
Discovery, mechanism and expected clinical significance of selective cytotoxicity of 2-chloro-2'-deoxyadenosine (2-CdA).
Archivum immunologiae et therapiae experimentalis 1994;42(1):1-5.
1993: Andrzej Górski; Pawel Grieb; Grazyna Korczak-Kowalska; Piotr Wierzbicki; B Stepień-Sopniewska; T Mrowiec
Cladribine (2-chloro-deoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro.
Immunopharmacology 1993;26(3):197-202.
1993: Andrzej Górski; Pawel Grieb; J Makula; B Stepień-Sopniewska; T Mrowiec; Maria Nowaczyk
2-Chloro-2-deoxyadenosine--a novel immunosuppressive agent.
Transplantation 1993;56(5):1253-7.
1993: Miroslaw Ryba; Pawel Grieb; M Pastuszko; B Wegier-Filipiuk; E Mrowiec; J Andrychowski; L Konopka
Impaired in vitro proliferative response of suppressor lymphocytes in patients with subarachnoid haemorrhage from ruptured intracranial aneurysm.
Acta neurochirurgica 1993;122(3-4):240-3.
1993: Miroslaw Ryba; Pawel Grieb; Michal Walski; J Sawicki; M Pastuszko
2-Chloro-2' deoxyadenosine prevents angiopathic changes in cerebral arteries in experimental SAH in rabbits.
Acta neurochirurgica 1993;122(1-2):118-21.
1993: Miroslaw Ryba; Pawel Grieb; M Pastuszko; J Bidziński; J Andrychowski; C Dziewiecki; P Bojarski; L Królicki
Successful prevention of neurological deficit in SAH patients with 2-chlorodeoxyadenosine.
Acta neurochirurgica 1993;124(2-4):61-5.
1992: Pawel Grieb
Antioxidant systems--physiology and pharmacotherapy trends.
Materia medica Polona. Polish journal of medicine and pharmacy 1992;24(4):217-22.
1992: Miroslaw Ryba; Pawel Grieb; I Podobińska; K Iwańska; M Pastuszko; A Górski
HLA antigens and intracranial aneurysms.
Acta neurochirurgica 1992;116(1):1-5.
1991: Miroslaw Ryba; Pawel Grieb; J Bidzinski; M Pastuszko; C Dziewiecki; K Iwanska
Cyclosporine A for the prevention of neurological deficit following subarachnoid hemorrhage.
Stroke; a journal of cerebral circulation 1991;22(4):531.